https://www.marketscreener.com/quote/stock/SAGE-THERAPEUTICS-INC-16917559/news/Company-Statement-Investigational-SAGE-718-Granted-Nonproprietary-Name-of-Dalzanemdor-45504144/?utm_source=telegram&utm_medium=social&utm_campaign=share